company background image
XRAY logo

DENTSPLY SIRONA NasdaqGS:XRAY Stock Report

Last Price

US$28.05

Market Cap

US$5.9b

7D

-0.7%

1Y

-24.5%

Updated

22 May, 2024

Data

Company Financials +

DENTSPLY SIRONA Inc.

NasdaqGS:XRAY Stock Report

Market Cap: US$5.9b

DENTSPLY SIRONA Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DENTSPLY SIRONA
Historical stock prices
Current Share PriceUS$28.05
52 Week HighUS$41.65
52 Week LowUS$26.27
Beta1
1 Month Change-7.64%
3 Month Change-16.44%
1 Year Change-24.45%
3 Year Change-58.07%
5 Year Change-47.78%
Change since IPO3,919.10%

Recent News & Updates

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Recent updates

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Mar 10
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Feb 16
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Jan 29
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jan 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 25
Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Nov 06
These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

Oct 15
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

Sep 18
An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

Jul 31
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Jul 09
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jun 20
A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Jun 02
When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

May 15
Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Apr 05
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Mar 07
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Nov 09
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona names Glenn Coleman as new CFO

Sep 22

Dentsply Sirona hires Simon Campion as president, CEO

Aug 25

Dentsply Sirona receives noncompliance notice from Nasdaq

Aug 16

Dentsply Sirona: Weakening Fundamentals Outweigh 'Defensives' Argument

Jul 18

Dentsply Sirona Seems Unaffected By Management Reshuffles

May 02

Investors Will Want DENTSPLY SIRONA's (NASDAQ:XRAY) Growth In ROCE To Persist

Apr 29
Investors Will Want DENTSPLY SIRONA's (NASDAQ:XRAY) Growth In ROCE To Persist

Shareholder Returns

XRAYUS Medical EquipmentUS Market
7D-0.7%1.1%1.2%
1Y-24.5%4.2%27.7%

Return vs Industry: XRAY underperformed the US Medical Equipment industry which returned 4.2% over the past year.

Return vs Market: XRAY underperformed the US Market which returned 27.7% over the past year.

Price Volatility

Is XRAY's price volatile compared to industry and market?
XRAY volatility
XRAY Average Weekly Movement3.1%
Medical Equipment Industry Average Movement8.3%
Market Average Movement5.9%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market2.8%

Stable Share Price: XRAY has not had significant price volatility in the past 3 months.

Volatility Over Time: XRAY's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
187715,000Simon Campionwww.dentsplysirona.com

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

DENTSPLY SIRONA Inc. Fundamentals Summary

How do DENTSPLY SIRONA's earnings and revenue compare to its market cap?
XRAY fundamental statistics
Market capUS$5.86b
Earnings (TTM)-US$95.00m
Revenue (TTM)US$3.94b

1.5x

P/S Ratio

-61.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XRAY income statement (TTM)
RevenueUS$3.94b
Cost of RevenueUS$1.87b
Gross ProfitUS$2.07b
Other ExpensesUS$2.17b
Earnings-US$95.00m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.46
Gross Margin52.61%
Net Profit Margin-2.41%
Debt/Equity Ratio64.9%

How did XRAY perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

-128%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.